Sherry Li
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 4
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
- Cystic Fibrosis Research Advances 2
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Jean‐François Martini (5 shared papers)Benjamin Besse (3 shared papers)Alice T. Shaw (3 shared papers)Benjamin Solomon (3 shared papers)Sai‐Hong Ignatius Ou (3 shared papers)Gregory J. Riely (3 shared papers)Todd M. Bauer (3 shared papers)Antonello Abbattista (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Journal of Clinical Oncology (2 papers)Future Oncology (2 papers)Icarus (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Sherry Li
17 papers receiving 693 citations
Sherry Li's Hit Papers
Peers
Comparison fields: 5 of 71
- Pulmonary and Respiratory Medicine 527
- Oncology 411
- Cancer Research 190
- Pathology and Forensic Medicine 76
- Molecular Biology 286
Countries citing papers authored by Sherry Li
This map shows the geographic impact of Sherry Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Li more than expected).
Fields of papers citing papers by Sherry Li
This network shows the impact of papers produced by Sherry Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Li. The network helps show where Sherry Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherry Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Hit paper breakdown → | 2019 | 269 |
| 2 | 2019 | 248 | |
| 3 | 2014 | 61 | |
| 4 | 2018 | 32 | |
| 5 | 2012 | 21 | |
| 6 | 2018 | 18 | |
| 7 | 2023 | 18 | |
| 8 | Manual of Medical Therapeutics | 1980 | 10 |
| 9 | 2019 | 8 | |
| 10 | 2018 | 7 | |
| 11 | 2020 | 5 | |
| 12 | 2004 | 5 | |
| 13 | 2018 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2025 | 3 | |
| 16 | 2025 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 0 | |
| 19 | 2022 | 0 |
About Sherry Li
Sherry Li is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Epidemiology, having authored 19 papers that have together received 718 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Renal cell carcinoma treatment (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cystic Fibrosis Research Advances (2 papers), Lung Cancer Research Studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Oral and gingival health research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (527 citations), Oncology (411 citations), Cancer Research (190 citations), Pathology and Forensic Medicine (76 citations) and Molecular Biology (286 citations). Sherry Li has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Jean‐François Martini, Benjamin Besse, Alice T. Shaw, Benjamin Solomon, Sai‐Hong Ignatius Ou, Gregory J. Riely, Todd M. Bauer, Antonello Abbattista, Holger Thurm and Ross A. Soo. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Future Oncology, Icarus and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.